By Tim Davis, Vice President, Digital Patient Solutions, ERT
Patient centricity in healthcare involves designing services and solutions around the patient. A key way of implementing this approach is by listening to the patient’s voice along their entire treatment journey. The Real-World Data (RWD) that this generates is becoming increasingly valuable in informing important healthcare decisions, and the wider Real-World Evidence (RWE) base that RWD feeds into can also generate significant returns on investment for pharma companies.
This article reviews current trends in Real-World Data (RWD) collection and how clinical trial sponsors can generate significant returns on investment by utilizing innovative technologies to overcome the perceived challenges that hinder some patient-centric initiatives.